<DOC>
	<DOCNO>NCT02856854</DOCNO>
	<brief_summary>EMB-001 combination 2 drug : cortisol synthesis inhibitor , metyrapone ( Metopirone® ) , benzodiazepine receptor agonist , oxazepam ( original trade name Serax® ; market oxazepam ( generic ) ) . This Phase 1b cocaine interaction study conduct order ass safety PK EMB-001 cocaine combination .</brief_summary>
	<brief_title>A Study Metyrapone Oxazepam Combination Product ( EMB-001 ) Cocaine</brief_title>
	<detailed_description>This single center , randomize , double-blinded , multiple-dose , PLB control , 2-period , 4-sequence , crossover study design . After establish eligibility approximately 16 subject cocaine use disorder randomize one four sequence . Treatment period separate 7-day in-patient washout period . EMB-001/PLB orally administer 7 consecutive day , BID 6 day ( start Day 1 Day 15 ) follow last day ( Day 7 Day 21 ) one EMB-001/PLB oral dose morning . Infusion 40 mg IV cocaine IV saline-to-match cocaine infusion administer randomized order , 2 hour apart , start 3 hour last morning EMB-001/PLB oral administration . The subject discharge research clinic 2 day last dose cocaine , follow-up visit 7 day last dose .</detailed_description>
	<mesh_term>Metyrapone</mesh_term>
	<mesh_term>Oxazepam</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>nontreatmentseeking cocaine user positive urine toxicology screen cocaine least screening medical history physical examination demonstrate clinically significant contraindication participate study male must use contraception ; female must nonchildbearing potential drug allergy reactions metyrapone benzodiazepine , severe hypersensitivity reaction ( like angioedema ) drug history clinically significant adverse reaction cocaine low outofrange serum cortisol value screen subject heighten likelihood adrenal insufficiency , sign history adrenal insufficiency confounders level cortisol and/or cortisol bind globulin treatment glucocorticoid history seizure , benzodiazepine use disorder , respiratory disease , neurologic neuromuscular disease , liver disease cardiovascular disease psychiatric substance use disorder clinical significance , suicidality clinically significant find medical history , physical examination , clinical laboratory test , vital sign ECGs use drug abnormal BP HR positive urine drug screen alcohol drug marijuana ( THC ) cocaine positive serology test result HIV1/HIV2 Antibodies , Hepatitis B surface Antigen ( HBsAg ) Hepatitis C Antibody ( HCVAb )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>